{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:09:46Z","timestamp":1793833786476,"version":"4.6.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX005717"],"award-info":[{"award-number":["I01BX005717"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031147","name":"Duke Claude D. Pepper Older Americans Independence Center, Duke Aging Center, Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008635","name":"University of Texas Health Science Center at San Antonio","doi-asserted-by":"publisher","award":["TL1TR002647"],"award-info":[{"award-number":["TL1TR002647"]}],"id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032645","name":"Hevolution Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032810","name":"Robert and Arlene Kogod Center on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016997","name":"Noaber Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000965","name":"American Federation for Aging Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG046170"],"award-info":[{"award-number":["U01AG046170"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG024904"],"award-info":[{"award-number":["U19AG024904"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG006786"],"award-info":[{"award-number":["U01AG006786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG068030"],"award-info":[{"award-number":["R01AG068030"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062677"],"award-info":[{"award-number":["P30AG062677"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U24AG057437"],"award-info":[{"award-number":["U24AG057437"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072947"],"award-info":[{"award-number":["P30AG072947"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG066546"],"award-info":[{"award-number":["P30AG066546"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["PTC REG-20-651687"],"award-info":[{"award-number":["PTC REG-20-651687"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"publisher","award":["GC-201908-2019443"],"award-info":[{"award-number":["GC-201908-2019443"]}],"id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK114920"],"award-info":[{"award-number":["U01DK114920"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["I01BX001340"],"award-info":[{"award-number":["I01BX001340"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008479","name":"Wake Forest School of Medicine Claude Pepper Older Americans Independence Center","doi-asserted-by":"publisher","award":["U24AG059624"],"award-info":[{"award-number":["U24AG059624"]}],"id":[{"id":"10.13039\/100008479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["UF1NS125417"],"award-info":[{"award-number":["UF1NS125417"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008636","name":"Institute for Integration of Medicine and Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University School of Medicine in Saint Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neurot.2025.e00591","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:35:54Z","timestamp":1745393754000},"page":"e00591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Valentina R.","family":"Garbarino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Palavicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Melendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas R.","family":"Barthelemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany F.","family":"Kautz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Lopez-Cruzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia J.","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarjunachary","family":"Ragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallin","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair Machado","family":"Espindola-Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Tchkonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Salardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Musi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitzi M.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda E.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neurot.2025.e00591_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","article-title":"Cellular senescence: defining a path forward","volume":"179","author":"Gorgoulis","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12840","article-title":"Tau protein aggregation is associated with cellular senescence in the brain","volume":"17","author":"Musi","year":"2018","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00591_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s43587-021-00142-3","article-title":"Profiling senescent cells in human brains reveals neurons with CDKN2D\/p19 and tau neuropathology","volume":"1","author":"Dehkordi","year":"2021","journal-title":"Nat Aging"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","article-title":"Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model","volume":"22","author":"Zhang","year":"2019","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00591_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045069","article-title":"Astrocyte senescence as a component of Alzheimer\u2019s disease","volume":"7","author":"Bhat","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00591_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/joim.13141","article-title":"Senolytic drugs: from discovery to translation","volume":"288","author":"Kirkland","year":"2020","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.18632\/aging.203835","article-title":"Combination of dasatinib and quercetin improves cognitive abilities in aged male Wistar rats, alleviates inflammation and changes hippocampal synaptic plasticity and histone H3 methylation profile","volume":"14","author":"Krzystyniak","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.neurot.2025.e00591_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114260","article-title":"Combined use of dasatinib and quercetin alleviates overtraining-induced deficits in learning and memory through eliminating senescent cells and reducing apoptotic cells in rat hippocampus","volume":"440","author":"Wang","year":"2023","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.neurot.2025.e00591_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111589","article-title":"A geroscience motivated approach to treat Alzheimer\u2019s disease: senolytics move to clinical trials","volume":"200","author":"Gonzales","year":"2021","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00591_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.14283\/jpad.2023.104","article-title":"Translating the biology of aging into new therapeutics for Alzheimer\u2019s disease: senolytics","volume":"10","author":"Riessland","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/joim.13775","article-title":"Focus on senescence: clinical significance and practical applications","volume":"295","author":"Boccardi","year":"2024","journal-title":"J Intern Med"},{"key":"10.1016\/j.neurot.2025.e00591_bib14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","article-title":"Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study","volume":"40","author":"Justice","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurot.2025.e00591_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00591_bib16","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","article-title":"Senolytic therapy in mild Alzheimer\u2019s disease: a phase 1 feasibility trial","volume":"29","author":"Gonzales","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00591_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41580-024-00738-8","article-title":"SenNet recommendations for detecting senescent cells in different tissues","volume":"25","author":"Suryadevara","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00591_bib19","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s43587-023-00446-6","article-title":"Spatial mapping of cellular senescence: emerging challenges and opportunities","volume":"3","author":"Gurkar","year":"2023","journal-title":"Nat Aging"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41398-021-01362-2","article-title":"Plasma lipidome is dysregulated in Alzheimer\u2019s disease and is associated with disease risk genes","volume":"11","author":"Liu","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00591_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cobeha.2019.01.008","article-title":"The conserved transcriptional response to adversity","volume":"28","author":"Cole","year":"2019","journal-title":"Curr Opin Behav Sci."},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14283\/jpad.2021.62","article-title":"Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): a pilot clinical trial","volume":"9","author":"Gonzales","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00591_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/alz.12697","article-title":"Comparative analytical performance of multiple plasma A\u03b242 and A\u03b240 assays and their ability to predict positron emission tomography amyloid positivity","volume":"19","author":"Zicha","year":"2023","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00591_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","article-title":"CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer\u2019s disease","volume":"3","author":"Barth\u00e9lemy","year":"2023","journal-title":"Nat Aging"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00591_bib25","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/s41591-023-02443-z","article-title":"CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer\u2019s disease","volume":"29","author":"Horie","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.neurot.2025.e00591_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-0716-0211-9_14","article-title":"Metabolite, protein, and lipid extraction (MPLEx): a method that simultaneously inactivates Middle East respiratory syndrome coronavirus and allows analysis of multiple host cell components following infection","volume":"2099","author":"Nicora","year":"2020","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11306-017-1312-x","article-title":"High-throughput extraction and quantification method for targeted metabolomics in murine tissues","volume":"14","author":"Zukunft","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/j.neurot.2025.e00591_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-7862-5_4","article-title":"Lipidomics profiling of myelin","volume":"1791","author":"Wang","year":"2018","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/mas.21492","article-title":"Selection of internal standards for accurate quantification of complex lipid species in biological extracts by electrospray ionization mass spectrometry-What, how and why?","volume":"36","author":"Wang","year":"2017","journal-title":"Mass Spectrom Rev"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00591_bib30","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/rcm.3595","volume":"22","author":"Han","year":"2008","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00591_bib31","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1021\/ac900241u","article-title":"Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics","volume":"81","author":"Yang","year":"2009","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00591_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib33","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It\u2019s not that simple","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.neurot.2025.e00591_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2025.111688","article-title":"To adjust, or not to adjust, for multiple comparisons","volume":"180","author":"Hooper","year":"2025","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.neurot.2025.e00591_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Corrigendum to \u2018Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease\u2019","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-020-00596-4","article-title":"Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer\u2019s disease and PET amyloid-positive patient identification","volume":"12","author":"Barth\u00e9lemy","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00591_bib37","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"Barth\u00e9lemy","year":"2020","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00591_bib38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13195-022-01117-1","article-title":"The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer\u2019s disease: a literature review","volume":"14","author":"Brand","year":"2022","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib40","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/brain\/awaa373","article-title":"CSF tau microtubule binding region identifies tau tangle and clinical stages of Alzheimer\u2019s disease","volume":"144","author":"Horie","year":"2020","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00591_bib41","doi-asserted-by":"crossref","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","article-title":"Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease","volume":"91","author":"McDade","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib42","article-title":"Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer\u2019s disease","volume":"12","author":"Dhiman","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00591_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1096\/fba.2020-00047","article-title":"Aging markers in human urine: a comprehensive, non-targeted LC-MS study","volume":"2","author":"Teruya","year":"2020","journal-title":"FASEB BioAdvances"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00591_bib44","article-title":"A systematic review on urinary biomarkers for early diagnosis of Alzheimer\u2019s disease (AD)","volume":"10","author":"Rani","year":"2020","journal-title":"Int J Nutr Pharmacol Neurol Dis"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(03)00422-7","article-title":"Apoptotic cells induce migration of phagocytes via Caspase-3-mediated release of a lipid attraction signal","volume":"113","author":"Lauber","year":"2003","journal-title":"Cell"},{"issue":"63","key":"10.1016\/j.neurot.2025.e00591_bib46","doi-asserted-by":"crossref","first-page":"106177","DOI":"10.18632\/oncotarget.22425","article-title":"Lysophosphatidylcholine induces cytotoxicity\/apoptosis and IL-8 production of human endothelial cells: related mechanisms","volume":"8","author":"Chang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neurot.2025.e00591_bib47","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3389\/fimmu.2019.02927","article-title":"Lysophosphatidylcholine induces NLRP3 inflammasome-mediated foam cell formation and pyroptosis in human monocytes and endothelial cells","volume":"10","author":"Corr\u00eaa","year":"2019","journal-title":"Front Immunol"},{"issue":"30","key":"10.1016\/j.neurot.2025.e00591_bib48","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.2174\/092986707782793899","article-title":"Role of lysophosphatidylcholine (LPC) in atherosclerosis","volume":"14","author":"Matsumoto","year":"2007","journal-title":"Curr Med Chem"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/glia.23245","article-title":"Mechanisms of lysophosphatidylcholine-induced demyelination: a primary lipid disrupting myelinopathy","volume":"66","author":"Plemel","year":"2018","journal-title":"Glia"},{"key":"10.1016\/j.neurot.2025.e00591_bib50","article-title":"Cellular senescence as a driver of cognitive decline triggered by chronic unpredictable stress","volume":"15","author":"Lin","year":"2021","journal-title":"Neurobiol Stress"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00591_bib51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.0000000000003537","article-title":"Long-term cortisol measures predict Alzheimer disease risk","volume":"88","author":"Ennis","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00591_bib52","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jocn.2008.12.026","article-title":"Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer\u2019s disease","volume":"16","author":"Huang","year":"2009","journal-title":"J Clin Neurosci"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib53","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41591-024-02973-0","article-title":"Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1\/2 trial interim results","volume":"30","author":"Sevigny","year":"2024","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib54","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1239","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-18042-1","article-title":"VEGFR2 alteration in Alzheimer\u2019s disease","volume":"7","author":"Cho","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib56","first-page":"91","article-title":"MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer\u2019s disease dementia phenotypes","volume":"3","author":"Bettcher","year":"2016","journal-title":"Alzheimer\u2019s Dementia: Diagn Assess Dis Monit"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib57","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1523\/JNEUROSCI.1333-19.2019","article-title":"Activated CX3CL1\/Smad2 signals prevent neuronal loss and Alzheimer\u2019s tau pathology-mediated cognitive dysfunction","volume":"40","author":"Fan","year":"2020","journal-title":"J Neurosci"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00591_bib58","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1161\/STROKEAHA.112.657411","article-title":"Higher plasma fractalkine is associated with better 6-month outcome from ischemic stroke","volume":"43","author":"Donohue","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40478-018-0557-6","article-title":"Phosphorylation of different tau sites during progression of Alzheimer\u2019s disease","volume":"6","author":"Neddens","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.neurot.2025.e00591_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103836","article-title":"Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer\u2019s disease","volume":"76","author":"Ashton","year":"2022","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00591_bib61","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1001\/jamaneurol.2022.3392","article-title":"Association of Donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial","volume":"79","author":"Pontecorvo","year":"2022","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib62","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3233\/JAD-2011-111076","article-title":"High-intensity physical activity modulates diet effects on cerebrospinal amyloid-\u03b2 levels in normal aging and mild cognitive impairment","volume":"28","author":"Baker","year":"2012","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00591_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib64","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1352458520912379","article-title":"Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis","volume":"27","author":"Uher","year":"2021","journal-title":"Mult Scler"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib65","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1046\/j.1471-4159.1996.67052013.x","article-title":"Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF","volume":"67","author":"Rosengren","year":"1996","journal-title":"J Neurochem"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00591_bib66","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurot.2025.e00591_bib67","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-60761-938-3_10","article-title":"Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging","volume":"686","author":"Kassner","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"S2","key":"10.1016\/j.neurot.2025.e00591_bib68","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.33549\/physiolres.934998","article-title":"Evaluation of blood-brain barrier integrity by the analysis of dynamic contrast-enhanced MRI - a comparison of quantitative and semi-quantitative methods","volume":"71","author":"Kala","year":"2022","journal-title":"Physiol Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib69","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00591_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10090357","article-title":"Targeted metabolic profiling of urine highlights a potential biomarker panel for the diagnosis of Alzheimer\u2019s disease and mild cognitive impairment: a pilot study","volume":"10","author":"Yilmaz","year":"2020","journal-title":"Metabolites"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00591_bib71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170341","article-title":"Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients","volume":"133","author":"Sharma","year":"2023","journal-title":"J Clin Investig"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00591_bib72","article-title":"Biofluid GPNMB\/osteoactivin as a potential biomarker of ageing: a cross-sectional study","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.neurot.2025.e00591_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103912","article-title":"Orally-active, clinically-translatable senolytics restore \u03b1-klotho in mice and humans","volume":"77","author":"Zhu","year":"2022","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib74","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00262-011-1096-1","article-title":"The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR-ABL tyrosine kinase inhibitors","volume":"61","author":"Schwarzbich","year":"2012","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib75","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00591_bib76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00591_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102591","article-title":"Lipid profiling of Alzheimer\u2019s disease brain highlights enrichment in glycerol(phospho)lipid, and sphingolipid metabolism","volume":"10","author":"Akyol","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00591_bib78","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1039\/D0MO00186D","article-title":"Cerebrospinal fluid lipidomics for biomarkers of Alzheimer\u2019s disease","volume":"17","author":"Byeon","year":"2021","journal-title":"Mol Omics"},{"key":"10.1016\/j.neurot.2025.e00591_bib79","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1038\/cddiscovery.2017.75","article-title":"A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence","volume":"3","author":"Flor","year":"2017","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.neurot.2025.e00591_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.796850","article-title":"Lipids as regulators of cellular senescence","volume":"13","author":"Hamsanathan","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.neurot.2025.e00591_bib81","series-title":"Multi-omics analyses reveal novel effects of PLC\u03b32 deficiency in the mouse brain","author":"Hopp","year":"2023"},{"key":"10.1016\/j.neurot.2025.e00591_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.784391","article-title":"The insulin-sensitizer pioglitazone remodels adipose tissue phospholipids in humans","volume":"12","author":"Palavicini","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.neurot.2025.e00591_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.732319","article-title":"Phospholipases and reactive oxygen species derived lipid biomarkers in healthy and diseased humans and animals - a focus on lysophosphatidylcholine","volume":"12","author":"Engel","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.neurot.2025.e00591_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"Liu","year":"2020","journal-title":"Life Sci"},{"issue":"24","key":"10.1016\/j.neurot.2025.e00591_bib85","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Bor\u00e9n","year":"2020","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00591_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11175030","article-title":"Plasma lipidomics approach in early and specific Alzheimer\u2019s disease diagnosis","volume":"11","author":"Pe\u00f1a-Bautista","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00591_bib87","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-160645","article-title":"Association between plasma ceramides and phosphatidylcholines and hippocampal brain volume in late onset Alzheimer\u2019s disease","volume":"60","author":"Kim","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"S3","key":"10.1016\/j.neurot.2025.e00591_bib89","article-title":"Investigating the importance of acylcarnitines in Alzheimer\u2019s disease","volume":"17","author":"Baloni","year":"2021","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib90","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155694","article-title":"Serum levels of acyl-carnitines along the continuum from normal to Alzheimer\u2019s dementia","volume":"11","author":"Cristofano","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib91","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cmet.2021.03.008","article-title":"Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis","volume":"33","author":"Wiley","year":"2021","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00591_bib92","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cmet.2018.12.008","article-title":"Obesity-induced cellular senescence drives anxiety and impairs neurogenesis","volume":"29","author":"Ogrodnik","year":"2019","journal-title":"Cell Metab"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00591_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10090339","article-title":"Lipid players of cellular senescence","volume":"10","author":"Millner","year":"2020","journal-title":"Metabolites"},{"issue":"10","key":"10.1016\/j.neurot.2025.e00591_bib94","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","article-title":"The metabolic roots of senescence: mechanisms and opportunities for intervention","volume":"3","author":"Wiley","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.neurot.2025.e00591_bib95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2015.07.001","article-title":"Loneliness, eudaimonia, and the human conserved transcriptional response to adversity","volume":"62","author":"Cole","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neurot.2025.e00591_bib96","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.socscimed.2017.03.005","article-title":"An index of the ratio of inflammatory to antiviral cell types mediates the effects of social adversity and age on chronic illness","volume":"185","author":"Simons","year":"2017","journal-title":"Soc Sci Med"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00591_bib97","article-title":"Social genomics, cognition, and well-being during the COVID-19 pandemic","volume":"16","author":"Bateman","year":"2024","journal-title":"Alzheimers Dement (Amst)."},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib98","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1091\/mbc.7.6.975","article-title":"Age-dependent alterations of c-fos and growth regulation in human fibroblasts expressing the HPV16 E6 protein","volume":"7","author":"Yan","year":"1996","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.neurot.2025.e00591_bib99","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2014.10.034","article-title":"\u0394FosB: a transcriptional regulator of stress and antidepressant responses","volume":"753","author":"Nestler","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib100","first-page":"1667","article-title":"Suppression of the growth factor-mediated induction of c-fos and down-modulation of AP-1-binding activity are not required for cellular senescence","volume":"8","author":"Lucibello","year":"1993","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00591_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108860","article-title":"COX2 regulates senescence secretome composition and senescence surveillance through PGE(2)","volume":"34","author":"Gon\u00e7alves","year":"2021","journal-title":"Cell Rep"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00591_bib102","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1158\/1078-0432.CCR-07-4120","article-title":"Function of JunB in transient amplifying cell senescence and progression of human prostate cancer","volume":"14","author":"Konishi","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00591_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109634","article-title":"Persistent JunB activation in fibroblasts disrupts stem cell niche interactions enforcing skin aging","volume":"36","author":"Maity","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2025.e00591_bib104","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fneur.2020.00929","article-title":"Interleukin-1\u03b2 drives cellular senescence of rat astrocytes induced by oligomerized amyloid \u03b2 peptide and oxidative stress","volume":"11","author":"Shang","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib105","first-page":"561","article-title":"Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines","volume":"10","author":"Shimizu","year":"1990","journal-title":"Mol Cell Biol"},{"issue":"45","key":"10.1016\/j.neurot.2025.e00591_bib106","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1038\/sj.onc.1203173","article-title":"Diverse functions of JNK signaling and c-Jun in stress response and apoptosis","volume":"18","author":"Lepp\u00e4","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.neurot.2025.e00591_bib107","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2020.01.019","article-title":"Stress and neurodegeneration","volume":"503","author":"Pe\u00f1a-Bautista","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.neurot.2025.e00591_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2022.102575","article-title":"How neurons die in Alzheimer\u2019s disease: Implications for neuroinflammation","volume":"75","author":"Mangalmurti","year":"2022","journal-title":"Curr Opin Neurobiol"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00591_bib109","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.clinthera.2020.02.018","article-title":"Psychological stress-induced immune response and risk of Alzheimer\u2019s disease in Veterans from operation enduring freedom and operation Iraqi freedom","volume":"42","author":"Kempuraj","year":"2020","journal-title":"Clin Ther"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00591_bib110","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/gerona\/glab002","article-title":"Senolytic combination of dasatinib and quercetin alleviates intestinal senescence and inflammation and modulates the gut microbiome in aged mice","volume":"76","author":"Saccon","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00591_bib111","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13767","article-title":"Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age","volume":"22","author":"Islam","year":"2023","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00591_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jagp.2023.09.014","article-title":"Geroscience-centric perspective for geriatric psychiatry: integrating aging biology with geriatric mental health research","volume":"32","author":"Diniz","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.neurot.2025.e00591_bib113","first-page":"113","article-title":"A pilot study of senolytics to improve cognition and mobility in older adults at risk for Alzheimer\u2019s disease","author":"Millar","year":"2025","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00591_bib114","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-024-01033-z","article-title":"Therapeutic targeting of senescent cells in the CNS","volume":"23","author":"Riessland","year":"2024","journal-title":"Nat Rev Drug Discov"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925000698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:46:26Z","timestamp":1778831186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1878747925000698"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00591","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00591"}}